Comments on ALLHAT and doxazosin

Table 1 Major results of the ALLHAT study

	Doxazosin	Chlorthalidone
Event	(%)	(%)
Coronary heart disease	6.3	6.3
Stroke	4.2	3.6^*
Combined cardiovascular disease	25.5	21.8^**
Congestive heart failure	8.1	4.5^**
Coronary revascularization	6.2	5.2^***

Results are presented as a percentage of those entered in each arm, either doxazosin or chlorthalidone. Data from [1]. ^*P = 0.04, ^**P < 0.001, ^***P = 0.05.

ISSN: 1745-6215